Search Results

There are 26789 results for: content related to: Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trial

  1. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  2. Associations between responses to interferon therapy and genetic variation in interleukin-28B and the core region of hepatitis C virus genotype 3a

    Journal of Medical Virology

    Volume 87, Issue 8, August 2015, Pages: 1361–1367, Keiichi Yamada, Masatoshi Ishigami, Teiji Kuzuya, Takashi Honda, Kazuhiko Hayashi and Hidemi Goto

    Version of Record online : 23 APR 2015, DOI: 10.1002/jmv.24084

  3. Abstract of Papers Submitted to the American Association of the Study of Liver Disease

    Hepatology

    Volume 22, Issue S4, October 1995, Pages: S107–S514,

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840220703

  4. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  5. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  6. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  7. Effect of interferon therapy on first and second recurrence after resection of hepatitis C virus-related hepatocellular carcinoma

    Hepatology Research

    Volume 42, Issue 6, June 2012, Pages: 564–573, Masayuki Sakae, Shoji Kubo, Shigekazu Takemura, Chikaharu Sakata, Takahiro Uenishi, Shintaro Kodai, Hiroji Shinkawa, Yorihisa Urata, Kazunori Ohata, Kazuhisa Kaneda, Takayoshi Nishioka, Akinori Nozawa and Shigefumi Suehiro

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1872-034X.2011.00959.x

  8. You have free access to this content
    Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 421–429, Norio Akuta, Fumitaka Suzuki, Miharu Hirakawa, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Kazuaki Chayama, Yusuke Nakamura and Hiromitsu Kumada

    Version of Record online : 26 MAR 2010, DOI: 10.1002/hep.23690

  9. You have free access to this content
    Anticarcinogenic impact of interferon therapy on the progression of hepatocellular carcinoma in patients with chronic viral infection

    Hepatology Research

    Volume 42, Issue 1, January 2012, Pages: 22–32, Soji Shimomura and Shuhei Nishiguchi

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1872-034X.2011.00889.x

  10. Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: e220–e224, T. Kawaguchi, T. Ide, M. Itou, M. Suetsugu, S. Yoshioka, M. Sakata, E. Taniguchi, T. Oriishi, S. Sumie, O. Tsuruta and M. Sata

    Version of Record online : 4 AUG 2011, DOI: 10.1111/j.1365-2893.2011.01501.x

  11. Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection

    Liver International

    Volume 29, Issue 1, January 2009, Pages: 126–132, Takehiro Hayashi, Akihiro Tamori, Manabu Nishikawa, Hiroyasu Morikawa, Masaru Enomoto, Hiroki Sakaguchi, Daiki Habu, Norifumi Kawada, Shoji Kubo, Shuhei Nishiguchi and Susumu Shiomi

    Version of Record online : 19 MAY 2008, DOI: 10.1111/j.1478-3231.2008.01772.x

  12. Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 21, Issue 1, January 2006 , Pages: 122–128, MASAFUMI IKEDA, SHIGETOSHI FUJIYAMA, MOTOHIKO TANAKA, MICHIO SATA, TATSUYA IDE, HIROSHI YATSUHASHI and HIROSHI WATANABE

    Version of Record online : 15 FEB 2006, DOI: 10.1111/j.1440-1746.2005.04083.x

  13. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients

    Liver International

    Volume 27, Issue 2, March 2007, Pages: 186–191, S. Kobayashi, T. Takeda, M. Enomoto, A. Tamori, N. Kawada, D. Habu, H. Sakaguchi, T. Kuroda, K. Kioka, S. R. Kim, T. Kanno, T. Ueda, M. Hirano, S. Fujimoto, H. Jomura, S. Nishiguchi and S. Seki

    Version of Record online : 23 JAN 2007, DOI: 10.1111/j.1478-3231.2006.01406.x

  14. Significance of miRNA-122 in chronic hepatitis C patients with serotype 1 on interferon therapy

    Hepatology Research

    Volume 45, Issue 1, January 2015, Pages: 88–96, Yasuhiro Kamo, Tatsuki Ichikawa, Hisamitsu Miyaaki, Shinjirou Uchida, Tohei Yamaguchi, Hidetaka Shibata, Takuya Honda, Naota Taura, Hajime Isomoto, Fuminao Takeshima and Kazuhiko Nakao

    Version of Record online : 27 JUN 2014, DOI: 10.1111/hepr.12317

  15. Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders

    Journal of Viral Hepatitis

    Volume 17, Issue 3, March 2010, Pages: 185–191, Y. Imai, S. Tamura, H. Tanaka, N. Hiramatsu, S. Kiso, Y. Doi, M. Inada, T. Nagase, T. Kitada, K. Imanaka, K. Fukuda, T. Takehara, A. Kasahara and N. Hayashi

    Version of Record online : 26 AUG 2009, DOI: 10.1111/j.1365-2893.2009.01163.x

  16. Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28B

    Hepatology Research

    Volume 43, Issue 6, June 2013, Pages: 580–588, Kazuhiko Hayashi, Yoshiaki Katano, Hiroko Masuda, Youji Ishizu, Teiji Kuzuya, Takashi Honda, Masatoshi Ishigami, Akihiro Itoh, Yoshiki Hirooka, Isao Nakano, Tetsuya Ishikawa, Fumihiro Urano, Kentaro Yoshioka, Hidenori Toyoda, Takashi Kumada and Hidemi Goto

    Version of Record online : 29 JAN 2013, DOI: 10.1111/hepr.12005

  17. You have free access to this content
    Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

    Hepatology

    Volume 49, Issue 3, March 2009, Pages: 739–744, Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Masahiro Kobayashi, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Miharu Hirakawa, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 24 OCT 2008, DOI: 10.1002/hep.22703

  18. Expert recommendations on the application of interferon for chronic hepatitis B

    Journal of Digestive Diseases

    Volume 14, Issue 12, December 2013, Pages: 626–637, Mo Bin Wan and Xin Hua Weng

    Version of Record online : 5 NOV 2013, DOI: 10.1111/1751-2980.12096

  19. Significance of hepatic resection for hepatocellular carcinoma with sustained virological response to interferon therapy for chronic hepatitis C

    Hepatology Research

    Volume 43, Issue 6, June 2013, Pages: 605–609, Keishi Sugimachi, Nao Kinjo, Masahiko Ikebe, Naoki Yamashita, Eiji Kajiwara, Koshi Mimori and Hidefumi Higashi

    Version of Record online : 12 NOV 2012, DOI: 10.1111/j.1872-034X.2012.01112.x

  20. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x